Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Qel-Qur-Tskhviris Sneul… | Healthcare Services | 15.3% | 65th pct | 268 |
| Rukhi Republican Hospit… | Healthcare Services | -9.2% | 14th pct | 268 |
| Iris Borchashvili Healt… | Healthcare Services | — | no FY data | 268 |
| Tbilisis Zghvis Hospita… | Healthcare Services | — | no FY data | 268 |
| Pirveli Saavadmqopo | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 2 of 5 peers filed FY2024. Switch to FY2019 (4 of 5).
| Ratio — FY 2024 | Qel-Qur-Tskhviris Sneul… | Rukhi Republican Hospit… | Iris Borchashvili Healt… | Tbilisis Zghvis Hospita… | Pirveli Saavadmqopo |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 91.6% | 100.0% | — | — | — |
| EBITDA Margin | 15.3% | -9.2% | — | — | — |
| EBITDAR | 2,364 | -1,003 | — | — | — |
| EBITDAR Margin | 19.4% | -8.7% | — | — | — |
| EBIT Margin | 12.6% | -19.8% | — | — | — |
| Net Profit Margin | 11.2% | -19.8% | — | — | — |
| Operating Expense % of Sales | 76.3% | 146.9% | — | — | — |
| Returns | |||||
| Return on Assets (ROA) | 34.9% | -11.0% | — | — | — |
| Return on Equity (ROE) | 41.9% | -18.6% | — | — | — |
| ROIC [EBIT / Invested Capital] | 49.9% | -18.6% | — | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | 0.0% | — | — | — |
| Debt-to-Equity | 0.00x | 0.00x | — | — | — |
| Debt-to-EBITDA | 0.00x | N/A | — | — | — |
| Equity-to-Assets | 83.2% | 59.0% | — | — | — |
| Net Debt | -177 | -12 | — | — | — |
| Cash & Equivalents | 177 | 12 | — | — | — |
| Total Debt | N/A | N/A | — | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 3.56x | 0.44x | — | — | — |
| Quick Ratio | 3.56x | 0.13x | — | — | — |
| Cash Ratio | 0.27x | 0.00x | — | — | — |
| Total Current Assets | 2,343 | 3,711 | — | — | — |
| Total Current Liabilities | 658 | 8,508 | — | — | — |
| Inventory | N/A | 2,584 | — | — | — |
| Trade Receivables | 1,917 | 1,115 | — | — | — |
| Trade Payables | 367 | 4,561 | — | — | — |
| Net Working Capital | 1,685 | -4,797 | — | — | — |
| Net Working Capital % of Revenue | 13.8% | -41.7% | — | — | — |
| Trade Working Capital | 1,550 | -862 | — | — | — |
| Trade Working Capital % of Revenue | 12.7% | -7.5% | — | — | — |
| Change in Trade Working Capital | N/A | N/A | — | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | — | — | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | — | — | — |
| Receivables Turnover | 6.36x | 10.31x | — | — | — |
| Days Sales Outstanding (DSO) | 57.4 | 35.4 | — | — | — |
| Payables Turnover | 2.80x | N/A | — | — | — |
| Days Payable Outstanding (DPO) | 130.5 | N/A | — | — | — |
| Cash Conversion Cycle | -73.1 days | 35.4 days | — | — | — |
| Asset Turnover | 3.12x | 0.55x | — | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 966 | -1,013 | — | — | — |
| Free Cash Flow (OCF − Capex proxy) | 598 | -1,013 | — | — | — |
| Cash Conversion (OCF / EBITDA) | 51.7% | N/A | — | — | — |
| Dividends Declared | N/A | 0 | — | — | — |
| Dividend Payout Ratio | N/A | N/A | — | — | — |